Skip to contentD
Dare Bioscience, Inc.
D
DAREDare Bioscience, Inc. Q2 2021 · 10-Q
Revenue$0.00$0.00no prior Q2 2020 on file Net Income-$9.16M-$9.16MN/M vs Q2 2020 EPS Diluted-$0.18-$0.18N/M vs Q2 2020 Operating Income-$9,162,926N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$11,791,454— ended Jun 30, 2021 · filed Aug 12, 2021 · 43 d after period end